Enabling Innovative Drug Discovery with Advanced Technologies
HitGen now has a research team of over 500 scientists and offers integrated services to enable drug discovery research from target to IND filing.
We also operates a flexible business model, ranging from a single capability-based fee for services (FFS), DEL screening, FBDD/SBDD screening, custom compound and library synthesis, computational and medicinal chemistry, integrated drug discovery projects, risk sharing projects and collaborative ventures.
We use cookies to provide a better web experience.
By using our site, you acknowledge our use of cookies and please read our Cookie Notice for
More information